Association between serum neopterin and inflammatory activation in chronic kidney disease

Mediators of Inflammation

Volumn 2012, Issue , 2012, Pages

  Yadav, Ashok Kumar ^a   Sharma, Vinod ^a   Jha, Vivekanand ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; GAMMA INTERFERON; INTERLEUKIN 6; NEOPTERIN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; BLOOD LEVEL; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; HUMAN TISSUE; INFLAMMATION; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; BLOOD; CHRONIC KIDNEY FAILURE; IMMUNOLOGY; MIDDLE AGED;

FEMALE; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-6; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; NEOPTERIN; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84866154388     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2012/476979     Document Type: Article

References (50)

1. Huber C., Batchelor J. R., Fuchs D., Immune response-associated production of neopterin. Release from macrophages primarily under control of interferon-gamma. Journal of Experimental Medicine 1984 160 1 310 316 2-s2.0-0021264311 (Pubitemid 14089799)
2. Hoffmann G., Wirleitner B., Fuchs D., Potential role of immune system activation-associated production of neopterin derivatives in humans. Inflammation Research 2003 52 8 313 321 2-s2.0-0042162960 10.1007/s00011-003- 1181-9 (Pubitemid 36995156)
3. Lhee H. Y., Kim H., Kwan J. J., Soo S. J., Kyu B. L., The clinical significance of serum and urinary neopterin levels in several renal diseases. Journal of Korean Medical Science 2006 21 4 678 682 2-s2.0-33746897297 (Pubitemid 44199323)
4. Aulitzky W. E., Tilg H., Nicderwieser D., Riccabona G., Obendorf L., Margreiter R., Pfaller W., Huber C., Comparison of serum neopterin levels and urinary neopterin excretion in renal allograft recipients. Clinical Nephrology 1988 29 5 248 252 2-s2.0-0023875834
5. Fahey J. L., Taylor J. M. G., Detels R., Hofmann B., Melmed R., Nishanian P., Giorgi J. V., The prognostic value of cellular and serologic markers in infection with human immunodeficiency virus type 1. New England Journal of Medicine 1990 322 3 166 172 2-s2.0-0025069873 (Pubitemid 20036390)
6. Halota W., Jaruga B., Pawkowska M., Serum neopterin and β 2-microglobulin concentration as 'prognostic markers' of AIDS natural history. Polski Merkuriusz Lekarski 2002 13 74 126 128 2-s2.0-0036375931 (Pubitemid 35033567)
7. Lin C. Y., Urinary neopterin as a new biochemical marker for the monitoring of disease activity and prognosis in membranous nephropathy associated with hepatitis B surface antigenemia. Nephron 1989 53 2 115 120 2-s2.0-0024430719
8. Aulitzky W., Frick J., Fuchs D., Significance of urinary neopterin in patients with malignant tumors of the genitourinary tract. Cancer 1985 55 5 1052 1055 2-s2.0-0021985028 (Pubitemid 15128667)
9. Bichler A., Fuchs D., Hausen A., Urinary neopterine excretion in patients with genital cancer. Clinical Biochemistry 1982 15 1 38 40 2-s2.0-0020048438 (Pubitemid 12130454)
10. Alber H. F., Duftner C., Wanitschek M., Dörler J., Schirmer M., Suessenbacher A., Frick M., Dichtl W., Pachinger O., Weidinger F., Neopterin, CD4+CD28- lymphocytes and the extent and severity of coronary artery disease. International Journal of Cardiology 2009 135 1 27 35 2-s2.0-67349273640 10.1016/j.ijcard.2008.03.010
11. Chin G. K., Adams C. L., Carey B. S., Shaw S., Tse W. Y., Kaminski E. R., The value of serum neopterin, interferon-gamma levels and interleukin-12B polymorphisms in predicting acute renal allograft rejection. Clinical and Experimental Immunology 2008 152 2 239 244 2-s2.0-42049089163 10.1111/j.1365-2249.2008.03632.x (Pubitemid 351520915)
12. Gupta S., Fredericks S., Schwartzman R. A., Holt D. W., Kaski J. C., Kluft C., Meijer P., Brussaard H. E., Krans H. M. J., Schuit A. J., Serum neopterin in acute coronary syndromes. Lancet 1997 349 9060 1252 1253 2-s2.0-19244373058 (Pubitemid 27190062)
13. Schumacher M., Halwachs G., Tatzber F., Fruhwald F. M., Zweiker R., Watzinger N., Eber B., Wilders-Truschnig M., Esterbauer H., Klein W., Increased neopterin in patients with chronic and acute coronary syndromes. Journal of the American College of Cardiology 1997 30 3 703 707 2-s2.0-0030983843 10.1016/S0735-1097(97)00172-1 (Pubitemid 27397650)
14. Weiss M. F., Rodby R. A., Justice A. C., Hricik D. E., Lewis E. J., Rohde R., Bain R. P., Evans J. K., Turlington T. R., Burrows P. K., Sheehan J., Pohl M., Berl T., Lemann J., Blumenthal S., Bresnahan S., Hebert L., Nahman N. S., Rodby R., McGill J., Whittier F., Cattran D., Hano J., Hunsicker L., Maxwell D., Porush J., Spitalewitz S., Shapiro K., Adler S., Tolchin N., Svetkey L., Sharon Z., Rausenbaum B., Breyer J., Shulman G., Free pentosidine and neopterin as markers of progression rate in diabetic nephropathy. Kidney International 1998 54 1 193 202 2-s2.0-7144264416 (Pubitemid 28288035)
15. Auer J., Berent R., Lassnig E., Weber T., Eber B., Prognostic significance of immune activation after acute coronary syndromes. Journal of the American College of Cardiology 2002 39 11 1878 2-s2.0-0037024205 (Pubitemid 34595303)
16. Erren M., Reinecke H., Junker R., Fobker M., Schulte H., Schurek J. O., Kropf J., Kerber S., Breithardt G., Assmann G., Cullen P., Systemic inflammatory parameters in patients with atherosclerosis of the coronary and peripheral arteries. Arteriosclerosis, Thrombosis, and Vascular Biology 1999 19 10 2355 2363 2-s2.0-0032849727 (Pubitemid 29477836)
17. Sasaki T., Takeishi Y., Suzuki S., Niizeki T., Kitahara T., Katoh S., Ishino M., Shishido T., Watanabe T., Kubota I., High serum level of neopterin is a risk factor of patients with heart failure. International Journal of Cardiology 2010 145 2 318 2-s2.0-77955866621 10.1016/j.ijcard.2009.11.042
18. Hermus L., Schuitemaker J. H. N., Tio R. A., Breek J. C., Slart R. H. J. A., de Boef E., Zeebregts C. J., Novel serum biomarkers in carotid artery stenosis: useful to identify the vulnerable plaque? Clinical Biochemistry 2011 44 16 1292 1298 2-s2.0-80054068135 10.1016/j.clinbiochem.2011.08.1141
19. Avci E., Coşkun Ş., Çakir E., Kurt Y., Akgül E. Ö., Bilgi C., Relations between concentrations of asymmetric dimethylarginine and neopterin as potential risk factors for cardiovascular diseases in haemodialysis-treated patients. Renal Failure 2008 30 8 784 790 2-s2.0-51849095918 10.1080/08860220802249009
20. Go A. S., Chertow G. M., Fan D., McCulloch C. E., Hsu C. Y., Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. New England Journal of Medicine 2004 351 13 1296 1370 2-s2.0-4644221457 10.1056/NEJMoa041031 (Pubitemid 39268908)
21. Kalantar-Zadeh K., Inflammatory marker mania in chronic kidney disease: Pentraxins at the crossroad of universal soldiers of inflammation. Clinical Journal of the American Society of Nephrology 2007 2 5 872 875 2-s2.0-34548846170 10.2215/CJN.02750707
22. Stenvinkel P., Inflammation in end-stage renal failure: could it be treated? Nephrology Dialysis Transplantation 2002 17 supplement 8 33 38 2-s2.0-0036060717 (Pubitemid 34918877)
23. Stenvinkel P., Inflammation in end-stage renal diseasea fire that burns within. Contributions to Nephrology 2005 149 185 199 2-s2.0-20544477223 10.1159/000085525 (Pubitemid 43265016)
24. Bologa R. M., Levine D. M., Parker T. S., Cheigh J. S., Serur D., Stenzel K. H., Rubin A. L., Interleukin-6 predicts hypoalbuminemia, hypocholesterolemia, and mortality in hemodialysis patients. American Journal of Kidney Diseases 1998 32 1 107 114 2-s2.0-0031808267 (Pubitemid 28311878)
25. Kimmel P. L., Phillips T. M., Simmens S. J., Peterson R. A., Weihs K. L., Alleyne S., Cruz I., Yanovski J. A., Veis J. H., Immunologic function and survival in hemodialysis patients. Kidney International 1998 54 1 236 244 2-s2.0-0031835451 10.1046/j.1523-1755.1998.00981.x (Pubitemid 28288040)
26. Fuchs D., Hausen A., Reibnegger G., Werner E. R., Dittrich V. P., Wachter H., Neopterin levels in long-term hemodialysis. Clinical Nephrology 1988 30 4 220 224 2-s2.0-0023696092
27. Godai K., Uemasu J., Kawasaki H., Clinical significance of serum and urinary neopterins in patients with chronic renal disease. Clinical Nephrology 1991 36 3 141 146 2-s2.0-0025884794
28. Oda K., Arai T., Nagase M., Increased serum and urinary neopterin in nephrotic syndrome indicate cell-mediated immune dysfunction. American Journal of Kidney Diseases 1999 34 4 611 617 2-s2.0-0032880085 (Pubitemid 29473045)
29. Yadav A. K., Jha V., CD4+CD28null cells are expanded and exhibit a cytolytic profile in end-stage renal disease patients on peritoneal dialysis. Nephrology Dialysis Transplantation 2011 26 5 1689 1694 2-s2.0-79955589566 10.1093/ndt/gfr010
30. Yadav A. K., Lal A., Jha V., Association of circulating fractalkine (CX3CL1) and CX3CR1(+)CD4(+) T cells with common carotid artery intima-media thickness in patients with chronic kidney disease. Journal of Atherosclerosis and Thrombosis 2011 18 11 958 965 2-s2.0-82455164442
31. Levey A. S., Bosch J. P., Lewis J. B., Greene T., Rogers N., Roth D., A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Annals of Internal Medicine 1999 130 6 461 470 2-s2.0-0033574249 (Pubitemid 29135798)
32. National Kidney Foundation, K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. American Journal of Kidney Diseases 2002 39 supplement 2 S1 S266 10.1016/S0272-6386(02) 70081-4
33. Pecoits-Filho R., Heimbürger O., Bárány P., Suliman M., Fehrman-Ekholm I., Lindholm B., Stenvinkel P., Associations between circulating inflammatory markers and residual renal function in CRF patients. American Journal of Kidney Diseases 2003 41 6 1212 1218 2-s2.0-0038100467 10.1016/S0272-6386(03)00353-6 (Pubitemid 36637976)
34. Jairam A., Das R., Aggarwal P. K., Kohli H. S., Gupta K. L., Sakhuja V., Jha V., Iron status, inflammation and hepcidin in ESRD patients: the confounding role of intravenous iron therapy. Indian Journal of Nephrology 2010 20 3 125 131 2-s2.0-77958046563 10.4103/0971-4065.70840
35. Pecoits-Filho R., Bárány P., Lindholm B., Heimbürger O., Stenvinkel P., Interleukin-6 is an independent predictor of mortality in patients starting dialysis treatment. Nephrology Dialysis Transplantation 2002 17 9 1684 1688 2-s2.0-0036712017 (Pubitemid 35012175)
36. Chiang C. K., Hsu S. P., Pai M. F., Peng Y. S., Ho T. I., Liu S. H., Hung K. Y., Tsai T. J., Interleukin-18 is a strong predictor of hospitalization in haemodialysis patients. Nephrology Dialysis Transplantation 2004 19 11 2810 2815 2-s2.0-8344241183 10.1093/ndt/gfh475 (Pubitemid 39480977)
37. Reddan D. N., Klassen P. S., Szczech L. A., Coladonato J. A., O'Shea S., Owen W. F., Lowrie E. G., White blood cells as a novel mortality predictor in haemodialysis patients. Nephrology Dialysis Transplantation 2003 18 6 1167 1173 2-s2.0-0038007955 10.1093/ndt/gfg066 (Pubitemid 36722520)
38. Zoccali C., Mallamaci F., Tripepi G., Cutrupi S., Parlongo S., Malatino L. S., Bonanno G., Rapisarda F., Fatuzzo P., Seminara G., Stancanelli B., Nicocia G., Buemi M., Fibrinogen, mortality and incident cardiovascular complications in end-stage renal failure. Journal of Internal Medicine 2003 254 2 132 139 2-s2.0-0041842760 10.1046/j.1365-2796.2003.01180.x (Pubitemid 36900436)
39. Stenvinkel P., Heimburger O., Wang T., Lindholm B., Bergstrom J., Elinder G., High serum hyaluronan indicates poor survival in renal replacement therapy. American Journal of Kidney Diseases 1999 34 6 1083 1088 2-s2.0-0032694169
40. Zimmermann J., Herrlinger S., Pruy A., Metzger T., Wanner C., Inflammation enhances cardiovascular risk and mortality in hemodialysis patients. Kidney International 1999 55 2 648 658 2-s2.0-0032935896 10.1046/j.1523-1755.1999.00273.x (Pubitemid 29082891)
41. Tong M., Carrero J. J., Qureshi A. R., Anderstam B., Heimbürger O., Bárány P., Axelsson J., Alvestrand A., Stenvinkel P., Lindholm B., Suliman M. E., Plasma pentraxin 3 in patients with chronic kidney disease: associations with renal function, protein-energy wasting, cardiovascular disease, and mortality. Clinical Journal of the American Society of Nephrology 2007 2 5 889 897 2-s2.0-34548848020 10.2215/CJN.00870207
42. Nijsten M. W. N., De Groot E. R., Ten Duis H. J., Klasen H. J., Hack C. E., Aarden L. A., Serum levels of interleukin-6 and acute phase responses. Lancet 1987 2 8564 921 2-s2.0-2642663388 (Pubitemid 17154782)
43. Schultz D. R., Arnold P. I., Properties of four acute phase proteins: C-reactive protein, serum amyloid A protein, α 1-acid glycoprotein, and fibrinogen. Seminars in Arthritis and Rheumatism 1990 20 3 129 147 2-s2.0-0025553450 10.1016/0049-0172(90)90055-K
44. Zaoui P., Hakim R. M., The effects of the dialysis membrane on cytokine release. Journal of the American Society of Nephrology 1994 4 9 1711 1718 2-s2.0-0028391291
45. Werner E. R., Werner-Felmayer G., Fuchs D., Hausen A., Reibnegger R., Yim J. J., Wachter H., Biochemistry and function of pteridine synthesis in human and murine macrophages. Pathobiology 1991 59 4 276 279 2-s2.0-0025931416
46. Garcia-Moll X., Coccolo F., Cole D., Kaski J. C., Serum Neopterin and complex stenosis morphology in patients with unstable angina. Journal of the American College of Cardiology 2000 35 4 956 962 2-s2.0-0034654628 10.1016/S0735-1097(99)00640-3 (Pubitemid 30189928)
47. Zouridakis E., Avanzas P., Arroyo-Espliguero R., Fredericks S., Kaski J. C., Markers of inflammation and rapid coronary artery disease progression in patients with stable angina pectoris. Circulation 2004 110 13 1747 1753 2-s2.0-4644337418 10.1161/01.CIR.0000142664.18739.92 (Pubitemid 39299216)
48. Pedersen E. R., Midttun O., Ueland P. M., Schartum-Hansen H., Seifert R., Igland J., Nordrehaug J. E., Ebbing M., Svingen G., Bleie O., Berge R., Nygård O., Systemic markers of interferon- γ -mediated immune activation and long-term prognosis in patients with stable coronary artery disease. Arteriosclerosis, Thrombosis, and Vascular Biology 2011 31 3 698 704 2-s2.0-79952194201 10.1161/ATVBAHA.110.219329
49. Schobersberger W., Hoffmann G., Grote J., Wachter H., Fuchs D., Induction of inducible nitric oxide synthase expression by neopterin in vascular smooth muscle cells. FEBS Letters 1995 377 3 461 464 2-s2.0-0029562828 10.1016/0014-5793(95)01393-8 (Pubitemid 26027163)
50. Werner-Felmayer G., Werner E. R., Fuchs D., Hausen A., Reibnegger G., Schmidt K., Weiss G., Wachter H., Pteridine biosynthesis in human endothelial cells. Impact on nitric oxide- mediated formation of cyclic GMP. Journal of Biological Chemistry 1993 268 3 1842 1846 2-s2.0-0027459585 (Pubitemid 2303358